0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Terlipressin Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-33X15022
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Terlipressin Injection Market Research Report 2023
BUY CHAPTERS

Global Terlipressin Injection Market Research Report 2025

Code: QYRE-Auto-33X15022
Report
May 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Terlipressin Injection Market

The global market for Terlipressin Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Terlipressin Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Terlipressin Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Terlipressin Injection include Hubei JX Bio Pharmaceutical Co., Ltd., Hainan Poly Pharm Co., Ltd., Hybio Pharmaceutical Co., Ltd., Ferring Pharmaceuticals Co., Ltd., Chinese Peptide Co., Ltd., EVER Pharma, Wellona Pharma, Trumac Healthcare, Mallinckrodt, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Terlipressin Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Terlipressin Injection.
The Terlipressin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Terlipressin Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Terlipressin Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Terlipressin Injection Market Report

Report Metric Details
Report Name Terlipressin Injection Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hubei JX Bio Pharmaceutical Co., Ltd., Hainan Poly Pharm Co., Ltd., Hybio Pharmaceutical Co., Ltd., Ferring Pharmaceuticals Co., Ltd., Chinese Peptide Co., Ltd., EVER Pharma, Wellona Pharma, Trumac Healthcare, Mallinckrodt
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Terlipressin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Terlipressin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Terlipressin Injection Market report?

Ans: The main players in the Terlipressin Injection Market are Hubei JX Bio Pharmaceutical Co., Ltd., Hainan Poly Pharm Co., Ltd., Hybio Pharmaceutical Co., Ltd., Ferring Pharmaceuticals Co., Ltd., Chinese Peptide Co., Ltd., EVER Pharma, Wellona Pharma, Trumac Healthcare, Mallinckrodt

What are the Application segmentation covered in the Terlipressin Injection Market report?

Ans: The Applications covered in the Terlipressin Injection Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Terlipressin Injection Market report?

Ans: The Types covered in the Terlipressin Injection Market report are Original Drugs, Generic Drugs

Recommended Reports

Injection Therapeutics

Urinary Health Drugs

Hemorrhagic & Pressure Care

1 Terlipressin Injection Market Overview
1.1 Product Definition
1.2 Terlipressin Injection by Type
1.2.1 Global Terlipressin Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Terlipressin Injection by Application
1.3.1 Global Terlipressin Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Terlipressin Injection Market Size Estimates and Forecasts
1.4.1 Global Terlipressin Injection Revenue 2020-2031
1.4.2 Global Terlipressin Injection Sales 2020-2031
1.4.3 Global Terlipressin Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Terlipressin Injection Market Competition by Manufacturers
2.1 Global Terlipressin Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Terlipressin Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Terlipressin Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Terlipressin Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Terlipressin Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Terlipressin Injection, Product Type & Application
2.7 Global Key Manufacturers of Terlipressin Injection, Date of Enter into This Industry
2.8 Global Terlipressin Injection Market Competitive Situation and Trends
2.8.1 Global Terlipressin Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Terlipressin Injection Players Market Share by Revenue
2.8.3 Global Terlipressin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Terlipressin Injection Market Scenario by Region
3.1 Global Terlipressin Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Terlipressin Injection Sales by Region: 2020-2031
3.2.1 Global Terlipressin Injection Sales by Region: 2020-2025
3.2.2 Global Terlipressin Injection Sales by Region: 2026-2031
3.3 Global Terlipressin Injection Revenue by Region: 2020-2031
3.3.1 Global Terlipressin Injection Revenue by Region: 2020-2025
3.3.2 Global Terlipressin Injection Revenue by Region: 2026-2031
3.4 North America Terlipressin Injection Market Facts & Figures by Country
3.4.1 North America Terlipressin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Terlipressin Injection Sales by Country (2020-2031)
3.4.3 North America Terlipressin Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Terlipressin Injection Market Facts & Figures by Country
3.5.1 Europe Terlipressin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Terlipressin Injection Sales by Country (2020-2031)
3.5.3 Europe Terlipressin Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Terlipressin Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Terlipressin Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Terlipressin Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Terlipressin Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Terlipressin Injection Market Facts & Figures by Country
3.7.1 Latin America Terlipressin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Terlipressin Injection Sales by Country (2020-2031)
3.7.3 Latin America Terlipressin Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Terlipressin Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Terlipressin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Terlipressin Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Terlipressin Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Terlipressin Injection Sales by Type (2020-2031)
4.1.1 Global Terlipressin Injection Sales by Type (2020-2025)
4.1.2 Global Terlipressin Injection Sales by Type (2026-2031)
4.1.3 Global Terlipressin Injection Sales Market Share by Type (2020-2031)
4.2 Global Terlipressin Injection Revenue by Type (2020-2031)
4.2.1 Global Terlipressin Injection Revenue by Type (2020-2025)
4.2.2 Global Terlipressin Injection Revenue by Type (2026-2031)
4.2.3 Global Terlipressin Injection Revenue Market Share by Type (2020-2031)
4.3 Global Terlipressin Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Terlipressin Injection Sales by Application (2020-2031)
5.1.1 Global Terlipressin Injection Sales by Application (2020-2025)
5.1.2 Global Terlipressin Injection Sales by Application (2026-2031)
5.1.3 Global Terlipressin Injection Sales Market Share by Application (2020-2031)
5.2 Global Terlipressin Injection Revenue by Application (2020-2031)
5.2.1 Global Terlipressin Injection Revenue by Application (2020-2025)
5.2.2 Global Terlipressin Injection Revenue by Application (2026-2031)
5.2.3 Global Terlipressin Injection Revenue Market Share by Application (2020-2031)
5.3 Global Terlipressin Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hubei JX Bio Pharmaceutical Co., Ltd.
6.1.1 Hubei JX Bio Pharmaceutical Co., Ltd. Company Information
6.1.2 Hubei JX Bio Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Hubei JX Bio Pharmaceutical Co., Ltd. Terlipressin Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hubei JX Bio Pharmaceutical Co., Ltd. Terlipressin Injection Product Portfolio
6.1.5 Hubei JX Bio Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Hainan Poly Pharm Co., Ltd.
6.2.1 Hainan Poly Pharm Co., Ltd. Company Information
6.2.2 Hainan Poly Pharm Co., Ltd. Description and Business Overview
6.2.3 Hainan Poly Pharm Co., Ltd. Terlipressin Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hainan Poly Pharm Co., Ltd. Terlipressin Injection Product Portfolio
6.2.5 Hainan Poly Pharm Co., Ltd. Recent Developments/Updates
6.3 Hybio Pharmaceutical Co., Ltd.
6.3.1 Hybio Pharmaceutical Co., Ltd. Company Information
6.3.2 Hybio Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Hybio Pharmaceutical Co., Ltd. Terlipressin Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hybio Pharmaceutical Co., Ltd. Terlipressin Injection Product Portfolio
6.3.5 Hybio Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Ferring Pharmaceuticals Co., Ltd.
6.4.1 Ferring Pharmaceuticals Co., Ltd. Company Information
6.4.2 Ferring Pharmaceuticals Co., Ltd. Description and Business Overview
6.4.3 Ferring Pharmaceuticals Co., Ltd. Terlipressin Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ferring Pharmaceuticals Co., Ltd. Terlipressin Injection Product Portfolio
6.4.5 Ferring Pharmaceuticals Co., Ltd. Recent Developments/Updates
6.5 Chinese Peptide Co., Ltd.
6.5.1 Chinese Peptide Co., Ltd. Company Information
6.5.2 Chinese Peptide Co., Ltd. Description and Business Overview
6.5.3 Chinese Peptide Co., Ltd. Terlipressin Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Chinese Peptide Co., Ltd. Terlipressin Injection Product Portfolio
6.5.5 Chinese Peptide Co., Ltd. Recent Developments/Updates
6.6 EVER Pharma
6.6.1 EVER Pharma Company Information
6.6.2 EVER Pharma Description and Business Overview
6.6.3 EVER Pharma Terlipressin Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 EVER Pharma Terlipressin Injection Product Portfolio
6.6.5 EVER Pharma Recent Developments/Updates
6.7 Wellona Pharma
6.7.1 Wellona Pharma Company Information
6.7.2 Wellona Pharma Description and Business Overview
6.7.3 Wellona Pharma Terlipressin Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Wellona Pharma Terlipressin Injection Product Portfolio
6.7.5 Wellona Pharma Recent Developments/Updates
6.8 Trumac Healthcare
6.8.1 Trumac Healthcare Company Information
6.8.2 Trumac Healthcare Description and Business Overview
6.8.3 Trumac Healthcare Terlipressin Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Trumac Healthcare Terlipressin Injection Product Portfolio
6.8.5 Trumac Healthcare Recent Developments/Updates
6.9 Mallinckrodt
6.9.1 Mallinckrodt Company Information
6.9.2 Mallinckrodt Description and Business Overview
6.9.3 Mallinckrodt Terlipressin Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Mallinckrodt Terlipressin Injection Product Portfolio
6.9.5 Mallinckrodt Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Terlipressin Injection Industry Chain Analysis
7.2 Terlipressin Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Terlipressin Injection Production Mode & Process Analysis
7.4 Terlipressin Injection Sales and Marketing
7.4.1 Terlipressin Injection Sales Channels
7.4.2 Terlipressin Injection Distributors
7.5 Terlipressin Injection Customer Analysis
8 Terlipressin Injection Market Dynamics
8.1 Terlipressin Injection Industry Trends
8.2 Terlipressin Injection Market Drivers
8.3 Terlipressin Injection Market Challenges
8.4 Terlipressin Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Terlipressin Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Terlipressin Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Terlipressin Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Terlipressin Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Terlipressin Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Terlipressin Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Terlipressin Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Terlipressin Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Terlipressin Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Terlipressin Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Terlipressin Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Terlipressin Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Terlipressin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Terlipressin Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Terlipressin Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Terlipressin Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Terlipressin Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Terlipressin Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Terlipressin Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Terlipressin Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Terlipressin Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Terlipressin Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Terlipressin Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Terlipressin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Terlipressin Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Terlipressin Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Terlipressin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Terlipressin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Terlipressin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Terlipressin Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Terlipressin Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Terlipressin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Terlipressin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Terlipressin Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Terlipressin Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Terlipressin Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Terlipressin Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Terlipressin Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Terlipressin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Terlipressin Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Terlipressin Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Terlipressin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Terlipressin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Terlipressin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Terlipressin Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Terlipressin Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Terlipressin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Terlipressin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Terlipressin Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Terlipressin Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Terlipressin Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Terlipressin Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Terlipressin Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Terlipressin Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Terlipressin Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Terlipressin Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Terlipressin Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Terlipressin Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Terlipressin Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Terlipressin Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Terlipressin Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Terlipressin Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Terlipressin Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Terlipressin Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Terlipressin Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Terlipressin Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Terlipressin Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Terlipressin Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Hubei JX Bio Pharmaceutical Co., Ltd. Company Information
 Table 71. Hubei JX Bio Pharmaceutical Co., Ltd. Description and Business Overview
 Table 72. Hubei JX Bio Pharmaceutical Co., Ltd. Terlipressin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Hubei JX Bio Pharmaceutical Co., Ltd. Terlipressin Injection Product
 Table 74. Hubei JX Bio Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 75. Hainan Poly Pharm Co., Ltd. Company Information
 Table 76. Hainan Poly Pharm Co., Ltd. Description and Business Overview
 Table 77. Hainan Poly Pharm Co., Ltd. Terlipressin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Hainan Poly Pharm Co., Ltd. Terlipressin Injection Product
 Table 79. Hainan Poly Pharm Co., Ltd. Recent Developments/Updates
 Table 80. Hybio Pharmaceutical Co., Ltd. Company Information
 Table 81. Hybio Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Hybio Pharmaceutical Co., Ltd. Terlipressin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Hybio Pharmaceutical Co., Ltd. Terlipressin Injection Product
 Table 84. Hybio Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 85. Ferring Pharmaceuticals Co., Ltd. Company Information
 Table 86. Ferring Pharmaceuticals Co., Ltd. Description and Business Overview
 Table 87. Ferring Pharmaceuticals Co., Ltd. Terlipressin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Ferring Pharmaceuticals Co., Ltd. Terlipressin Injection Product
 Table 89. Ferring Pharmaceuticals Co., Ltd. Recent Developments/Updates
 Table 90. Chinese Peptide Co., Ltd. Company Information
 Table 91. Chinese Peptide Co., Ltd. Description and Business Overview
 Table 92. Chinese Peptide Co., Ltd. Terlipressin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Chinese Peptide Co., Ltd. Terlipressin Injection Product
 Table 94. Chinese Peptide Co., Ltd. Recent Developments/Updates
 Table 95. EVER Pharma Company Information
 Table 96. EVER Pharma Description and Business Overview
 Table 97. EVER Pharma Terlipressin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. EVER Pharma Terlipressin Injection Product
 Table 99. EVER Pharma Recent Developments/Updates
 Table 100. Wellona Pharma Company Information
 Table 101. Wellona Pharma Description and Business Overview
 Table 102. Wellona Pharma Terlipressin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Wellona Pharma Terlipressin Injection Product
 Table 104. Wellona Pharma Recent Developments/Updates
 Table 105. Trumac Healthcare Company Information
 Table 106. Trumac Healthcare Description and Business Overview
 Table 107. Trumac Healthcare Terlipressin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Trumac Healthcare Terlipressin Injection Product
 Table 109. Trumac Healthcare Recent Developments/Updates
 Table 110. Mallinckrodt Company Information
 Table 111. Mallinckrodt Description and Business Overview
 Table 112. Mallinckrodt Terlipressin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Mallinckrodt Terlipressin Injection Product
 Table 114. Mallinckrodt Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Terlipressin Injection Distributors List
 Table 118. Terlipressin Injection Customers List
 Table 119. Terlipressin Injection Market Trends
 Table 120. Terlipressin Injection Market Drivers
 Table 121. Terlipressin Injection Market Challenges
 Table 122. Terlipressin Injection Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Terlipressin Injection
 Figure 2. Global Terlipressin Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Terlipressin Injection Market Share by Type: 2024 & 2031
 Figure 4. Original Drugs Product Picture
 Figure 5. Generic Drugs Product Picture
 Figure 6. Global Terlipressin Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Terlipressin Injection Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global Terlipressin Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Terlipressin Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Terlipressin Injection Sales (2020-2031) & (K Units)
 Figure 14. Global Terlipressin Injection Average Price (US$/Unit) & (2020-2031)
 Figure 15. Terlipressin Injection Report Years Considered
 Figure 16. Terlipressin Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Terlipressin Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Terlipressin Injection Players: Market Share by Revenue in Terlipressin Injection in 2024
 Figure 19. Terlipressin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Terlipressin Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Terlipressin Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Terlipressin Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Terlipressin Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Terlipressin Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Terlipressin Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Terlipressin Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Terlipressin Injection Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Terlipressin Injection Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Terlipressin Injection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Terlipressin Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Terlipressin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Terlipressin Injection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Terlipressin Injection by Type (2020-2031)
 Figure 53. Global Terlipressin Injection Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Terlipressin Injection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Terlipressin Injection by Application (2020-2031)
 Figure 56. Global Terlipressin Injection Price (US$/Unit) by Application (2020-2031)
 Figure 57. Terlipressin Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart